These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 14870638)

  • 21. Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases.
    Penner R; Fedorak RN; Madsen KL
    Curr Opin Pharmacol; 2005 Dec; 5(6):596-603. PubMed ID: 16214413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical indications for probiotics: an overview.
    Goldin BR; Gorbach SL
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S96-100; discussion S144-51. PubMed ID: 18181732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics.
    Gionchetti P; Lammers KM; Rizzello F; Campieri M
    Gastroenterol Clin North Am; 2005 Sep; 34(3):499-513, ix-x. PubMed ID: 16084310
    [No Abstract]   [Full Text] [Related]  

  • 25. [Probiotics in the era of evidence-based medicine. Humbug or significant therapy?].
    Füessl HS
    MMW Fortschr Med; 2002 Nov; 144(48):6-8. PubMed ID: 12532535
    [No Abstract]   [Full Text] [Related]  

  • 26. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
    Mitsuyama K; Sata M
    Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Probiotic drug therapy with E. coli strain Nissle 1917 (EcN): results of a prospective study of the records of 3,807 patients].
    Krammer HJ; Kämper H; von Bünau R; Zieseniss E; Stange C; Schlieger F; Clever I; Schulze J
    Z Gastroenterol; 2006 Aug; 44(8):651-6. PubMed ID: 16902895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probiotics: facts and myths.
    Senok AC; Ismaeel AY; Botta GA
    Clin Microbiol Infect; 2005 Dec; 11(12):958-66. PubMed ID: 16307549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review article: Probiotics in gastrointestinal and liver diseases.
    Jonkers D; Stockbrügger R
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():133-48. PubMed ID: 18081657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of probiotics in childhood gastrointestinal disorders.
    Vanderhoof JA; Young RJ
    J Pediatr Gastroenterol Nutr; 1998 Sep; 27(3):323-32. PubMed ID: 9740206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probiotics in infective diarrhoea and inflammatory bowel diseases.
    Gionchetti P; Rizzello F; Venturi A; Campieri M
    J Gastroenterol Hepatol; 2000 May; 15(5):489-93. PubMed ID: 10847433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probiotics for Gastrointestinal Conditions: A Summary of the Evidence.
    Wilkins T; Sequoia J
    Am Fam Physician; 2017 Aug; 96(3):170-178. PubMed ID: 28762696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diet in inflammatory bowel disease.
    Issa M; Saeian K
    Nutr Clin Pract; 2011 Apr; 26(2):151-4. PubMed ID: 21447767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy of probiotics: review of the evidence with focus on children.
    ; Michail S; Sylvester F; Fuchs G; Issenman R
    J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):550-7. PubMed ID: 17033538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease.
    Karimi O; Peña AS
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S136-41. PubMed ID: 18806706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical usefulness of probiotics in inflammatory bowel diseases.
    Mach T
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of a nursing model to understand diarrhea and the role of probiotics in patients with inflammatory bowel disease.
    Savard J; Sawatzky JA
    Gastroenterol Nurs; 2007; 30(6):418-23; quiz 424-5. PubMed ID: 18156958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Probiotics in gastrointestinal pathology].
    Cijevschi C; Rezmireş A; Mihai C; Miuţescu E
    Rev Med Chir Soc Med Nat Iasi; 2002; 107(2):264-7. PubMed ID: 12638270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotics: their role in the treatment and prevention of disease.
    Doron S; Gorbach SL
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):261-75. PubMed ID: 16597207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probiotics to enhance anti-infective defences in the gastrointestinal tract.
    Gill HS
    Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):755-73. PubMed ID: 14507586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.